This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Lars Englberger Hendrik Tevaearai Thierry P. Carrel Permission Requests Citing Articles Citing Articles via HighWire Google Scholar Articles by Englberger, L. Articles by Carrel, T. P. PubMed PubMed Citation Articles by Englberger, L. Articles by Carrel, T. P. Related Collections Related Articles

Different anticoagulation strategies in off-pump coronary artery bypass operations: a European survey

Department of Cardiovascular Surgery, Inselspital, University Hospital, Freiburgstrasse, 3010 Berne, Switzerland

*Corresponding author. Tel.: +41-31-632 2375; fax: +41-31-632 4443.

E-mail address: lars.englberger{at}insel.ch (L. Englberger).

In order to determine anticoagulation strategies in OPCAB a questionnaire survey among 750 European cardio-thoracic surgeons was performed. Questions addressed volume of OPCAB procedures performed, intra- and perioperative heparinization and antiplatelet therapy, as well as perioperative management. A total of 325 (43.7%) questionnaires were returned and validated. Perioperative protocols for administration of antiplatelets differed among the respondent surgeons. Perioperative prophylaxis of thrombosis (low or high molecular weight heparin) is performed by 78%. Intraoperative heparin dosage range between 70 U/kg to 500 U/kg, 60% of respondents prefer a low-dose regimen (150 U/kg). Correspondingly, the lowest activated clotting time (ACT) during surgery is accepted to be 200 s by 24%, 250 s by 18% and 300 s by 26% of surgeons. Protamine is used by 91% of respondents, while 52% perform a 1:1 reversal. A cell-saver and antifibrinolytics are used by 70% and 40%, respectively. Interestingly, 56% of respondents think bleeding in OPCAB patients is not reduced when compared to on-pump CABG. In addition, 34% of respondents believe there is an increased risk of early graft occlusion following OPCAB. This survey demonstrates widely different intra- and perioperative anticoagulation strategies for OPCAB procedures among European surgeons.

Key Words: OPCAB; Anticoagulation

Related Articles

HIT in OPCAB surgery

Karsten Knobloch, Andreas Gohritz, Marcus Spies, and Peter M. Vogt
Interactive CardioVascular and Thoracic Surgery 2008 7: 382. [Full Text] [PDF]

This article has been cited by other articles:

				K. Knobloch, A. Gohritz, M. Spies, and P. M. Vogt HIT in OPCAB surgery Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 382 - 382. [Full Text] [PDF]

				E. Apostolakis and I. Koniari Is anticoagulation management more significant for patients undergoing off-pump bypass than for those after CABG? Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 383 - 383. [Full Text] [PDF]